Peptide Nucleic Acids and Gene Editing: Perspectives on Structure and Repair.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
08 Feb 2020
Historique:
received: 16 01 2020
revised: 05 02 2020
accepted: 06 02 2020
entrez: 13 2 2020
pubmed: 13 2 2020
medline: 24 11 2020
Statut: epublish

Résumé

Unusual nucleic acid structures are salient triggers of endogenous repair and can occur in sequence-specific contexts. Peptide nucleic acids (PNAs) rely on these principles to achieve non-enzymatic gene editing. By forming high-affinity heterotriplex structures within the genome, PNAs have been used to correct multiple human disease-relevant mutations with low off-target effects. Advances in molecular design, chemical modification, and delivery have enabled systemic in vivo application of PNAs resulting in detectable editing in preclinical mouse models. In a model of β-thalassemia, treated animals demonstrated clinically relevant protein restoration and disease phenotype amelioration, suggesting a potential for curative therapeutic application of PNAs to monogenic disorders. This review discusses the rationale and advances of PNA technologies and their application to gene editing with an emphasis on structural biochemistry and repair.

Identifiants

pubmed: 32046275
pii: molecules25030735
doi: 10.3390/molecules25030735
pmc: PMC7037966
pii:
doi:

Substances chimiques

Peptide Nucleic Acids 0
DNA 9007-49-2

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : UH3 HL147352
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI145965
Pays : United States
Organisme : NHLBI NIH HHS
ID : F30 HL149185
Pays : United States
Organisme : NIGMS NIH HHS
ID : 5T32GM007223
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL125892
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139756
Pays : United States
Organisme : NHLBI NIH HHS
ID : F30HL149185
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007205
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32GM07205
Pays : United States
Organisme : NHLBI NIH HHS
ID : UG3 HL147352
Pays : United States
Organisme : NHLBI NIH HHS
ID : F30HL134252
Pays : United States

Références

Mol Carcinog. 2009 Apr;48(4):389-99
pubmed: 19072762
Cell Rep. 2016 Nov 8;17(7):1872-1881
pubmed: 27829157
Biochemistry. 2003 Dec 2;42(47):13987-95
pubmed: 14636067
J Neurochem. 2008 Feb;104(4):1055-64
pubmed: 17986221
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10648-52
pubmed: 8248156
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16695-700
pubmed: 12461167
Biochemistry. 2003 Dec 2;42(47):13996-4003
pubmed: 14636068
Mol Ther. 2011 Jan;19(1):172-80
pubmed: 20859257
J Biol Chem. 1999 Apr 23;274(17):11541-8
pubmed: 10206960
Nature. 1993 Oct 7;365(6446):566-8
pubmed: 7692304
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2637-41
pubmed: 7708697
Biochimie. 1999 Jan-Feb;81(1-2):15-25
pubmed: 10214906
Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7879-83
pubmed: 8356097
Chem Biol. 2011 Sep 23;18(9):1189-98
pubmed: 21944757
Science. 1991 Dec 6;254(5037):1497-500
pubmed: 1962210
Biosens Bioelectron. 2011 Jan 15;26(5):1918-23
pubmed: 20580217
Biochem Pharmacol. 1994 Sep 15;48(6):1310-3
pubmed: 7945427
Acta Biomater. 2018 Jun;73:38-51
pubmed: 29653217
J Am Chem Soc. 2006 Aug 9;128(31):10258-67
pubmed: 16881656
J Org Chem. 2011 Jul 15;76(14):5614-27
pubmed: 21619025
J Biol Chem. 2001 May 25;276(21):18018-23
pubmed: 11278954
RNA. 2008 Feb;14(2):336-46
pubmed: 18073344
J Am Chem Soc. 2010 Aug 11;132(31):10717-27
pubmed: 20681704
Science. 1996 Feb 9;271(5250):802-5
pubmed: 8628995
Mol Ther. 2013 Mar;21(3):580-7
pubmed: 23337982
Nat Commun. 2018 Jun 26;9(1):2481
pubmed: 29946143
Mol Ther Nucleic Acids. 2020 Mar 6;19:683-695
pubmed: 31945727
Biophys J. 2007 Oct 1;93(7):2363-72
pubmed: 17557792
J Control Release. 2019 Nov 28;314:92-101
pubmed: 31654688
Mol Cell Biol. 1995 Mar;15(3):1759-68
pubmed: 7862165
Adv Healthc Mater. 2015 Feb 18;4(3):361-6
pubmed: 25156908
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11804-8
pubmed: 10518531
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8922-6
pubmed: 2827160
Nucleic Acids Res. 2005 Nov 30;33(21):6837-49
pubmed: 16321967
Hum Mol Genet. 2010 Aug 15;19(16):3266-81
pubmed: 20542988
Stem Cells. 2014 Jul;32(7):1817-30
pubmed: 24753122
Chem Biol. 2005 Aug;12(8):923-9
pubmed: 16125104
Mol Ther. 2012 Jan;20(1):109-18
pubmed: 21829173
Biochemistry. 2005 Mar 15;44(10):3856-64
pubmed: 15751961
J Control Release. 2011 Oct 30;155(2):312-6
pubmed: 21620910
J Cell Biol. 2011 Nov 28;195(5):709-20
pubmed: 22123859
Molecules. 2018 Mar 11;23(3):
pubmed: 29534473
Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):E924-32
pubmed: 24556991
Genes Dev. 1993 Sep;7(9):1766-78
pubmed: 8370525
Stem Cell Res. 2015 Nov;15(3):715-721
pubmed: 26599326
J Mol Biol. 2013 Nov 29;425(23):4767-81
pubmed: 24095858
FEBS Lett. 1995 Nov 20;375(3):27-9
pubmed: 7498515
Gene Ther. 2013 Jun;20(6):658-69
pubmed: 23076379
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13514-9
pubmed: 18757759
J Am Chem Soc. 2009 Sep 2;131(34):12088-90
pubmed: 19663424
J Control Release. 2016 Oct 28;240:302-311
pubmed: 26776051
Annu Rev Biochem. 1995;64:65-95
pubmed: 7574496
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13003-8
pubmed: 11087855
J Control Release. 2012 Nov 28;164(1):41-8
pubmed: 23041278
Nat Commun. 2015 Apr 27;6:6952
pubmed: 25914116
Mol Cell Biol. 1996 Dec;16(12):6820-8
pubmed: 8943337
Nat Rev Genet. 2018 Dec;19(12):770-788
pubmed: 30323312
J Mol Recognit. 1994 Sep;7(3):165-70
pubmed: 7880540
Nat Genet. 2018 Aug;50(8):1132-1139
pubmed: 30054595
Mol Ther Nucleic Acids. 2013 Nov 19;2:e135
pubmed: 24253260
Nat Commun. 2016 Oct 26;7:13304
pubmed: 27782131
Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6460-5
pubmed: 16608910
Nucleic Acids Res. 1998 Nov 1;26(21):4910-6
pubmed: 9776752
Adv Drug Deliv Rev. 2009 Sep 30;61(11):953-64
pubmed: 19538995
Curr Gene Ther. 2014;14(5):331-42
pubmed: 25174576
Biosci Rep. 2018 Sep 20;38(5):
pubmed: 30209206
Mol Imaging Biol. 2016 Oct;18(5):686-96
pubmed: 27074841
Nanomedicine. 2010 Oct;6(5):662-71
pubmed: 20230912
Nature. 2015 Feb 5;518(7537):107-10
pubmed: 25409146
J Virol. 1993 Dec;67(12):7324-31
pubmed: 8230456
Nature. 1953 Apr 25;171(4356):737-8
pubmed: 13054692
Science. 1995 Dec 15;270(5243):1838-41
pubmed: 8525381
Cell Rep. 2018 Jan 30;22(5):1200-1210
pubmed: 29386108
Oligonucleotides. 2006 Summer;16(2):196-201
pubmed: 16764543
Methods Mol Biol. 2014;1050:193-205
pubmed: 24297361
Nucleic Acids Res. 2009 Jun;37(11):3635-44
pubmed: 19364810
Chem Soc Rev. 2011 Dec;40(12):5893-909
pubmed: 21901191
J Am Chem Soc. 2003 Jun 11;125(23):6878-9
pubmed: 12783535
Nat Biotechnol. 1998 Sep;16(9):857-61
pubmed: 9743120
Chembiochem. 2012 Jan 2;13(1):56-60
pubmed: 22135012
Nat Mater. 2009 Jun;8(6):526-33
pubmed: 19404239
Mol Pharm. 2020 Feb 3;17(2):461-471
pubmed: 31855437
Pharmaceuticals (Basel). 2012 Nov 01;5(11):1177-209
pubmed: 24223492
J Mol Biol. 2001 Mar 16;307(1):67-74
pubmed: 11243804
Mol Cell Biol. 2000 Feb;20(3):990-1000
pubmed: 10629056
Nucleic Acids Res. 1995 Jan 25;23(2):217-22
pubmed: 7862524

Auteurs

Nicholas G Economos (NG)

Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.

Stanley Oyaghire (S)

Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Elias Quijano (E)

Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.

Adele S Ricciardi (AS)

Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.

W Mark Saltzman (WM)

Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.

Peter M Glazer (PM)

Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH